Sign in

ISRV Epidemiology Group

@isirvepi.bsky.social
109 followers 287 following 3 posts

The ISRV Epidemiology Group aims to promote the scientific understanding of how respiratory viruses spread in populations.

PostsRepliesMedia
Reposted by ISRV Epidemiology Group
The Journal of Immunology @jimmunol.bsky.social · 22/04/2026
A summary of the NIH Aging and Trans-NIH Chronic Inflammation Working Group meeting, which explored recent advances and gaps in our understanding of the role of inflammaging in disease development, can be found in the Immunology Notes and Resources: ow.ly/OXcR50YNCJE.
Hallmarks of aging contributing to inflammaging. Aging is accompanied by multiple interconnected cellular and molecular alterations, including genomic instability, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, and immune dysregulation that collectively drive chronic, low-grade inflammaging. Adapted with permission from Guimaraes et al.30
041
Reposted by ISRV Epidemiology Group
Vaccine Safety Initiative @vaccinesafety.bsky.social · 20/04/2026
Even the ducks outside Messe München seem ready for tomorrow’s avian flu session 🦆 08:30 at #ESCMIDGlobal2026 | Hall ICM 13a with @escmid.bsky.social , @esgrev-escmid.bsky.social , @isrv.bsky.social, @isirvepi.bsky.social , @ecdc.europa.eu & @ema.europa.eu Early start—but worth it. 🔆
032
Reposted by ISRV Epidemiology Group
Vaccine Safety Initiative @vaccinesafety.bsky.social · 24/03/2026
Prevention improves wellbeing 🌿 A 2024 Nature Medicine analysis shows that reducing infectious disease burden—through measures like vaccination, ventilation, and hygiene—has measurable benefits for population health & resilience. 🔗 www.nature.com/articles/s41... #Prevention #PublicHealth #VIVI
155
Reposted by ISRV Epidemiology Group
ESWI @eswinfluenza.bsky.social · 20/02/2026
📩 The #ESWI #Fluzine for #February is live! 💻 #IDC Kick-off | 5 Mar, Online — respiratory viruses & #NCDs 📅 ESWI Summit | 11 Jun, Brussels — vaccines & immunisation policy 🎥 #ESWI2025 Science Policy sessions now available 📍 Explore our #ESWIEducationHub 🔗 mailchi.mp/eswi/fluzine...
012
Reposted by ISRV Epidemiology Group
Junior Einsteins Science Club® @junioreinsteins.bsky.social · 21/02/2026
Award winning STEM holiday camps for curious kids. The highlight of every school holiday break. Book now www.junioreinsteinsscienceclub.com #KidsCamps #HolidayCamps #SchoolHolidayCamps #EasterCamps #HalfTermCamps #MidTermCamps #WinterCamps #PADayCamps #KidsActivities #junioreinsteins
032
ISRV Epidemiology Group @isirvepi.bsky.social · 21/02/2026
🛎️ … Not just a respiratory virus!
001
Reposted by ISRV Epidemiology Group
International Society for Infectious Diseases (ISID) @isid.org · 14/02/2026
Viral hepatitis remains a major global health challenge, with many individuals undiagnosed or lost to follow-up. Learn how to bridge gaps in screening and treatment in this live webinar, hosted by PRIME Education, on March 10, 2026. 📆 Register here: ow.ly/Rwnp50Y9il5 #ISID #CME #MedEd
001
Reposted by ISRV Epidemiology Group
ESCMID @escmid.bsky.social · 23/12/2025
💡An important commentary on vaccines from ESCMID by the Vaccines Subcommittee Director, the Chair of the Vaccines Study Group & the ESCMID Executive Committee jointly published in CMI & CMI Comms. CMI: ow.ly/HUGM50XNByv CMI Comms: ow.ly/xmbk50XNByx #IDSky #clinmicro
175
Reposted by ISRV Epidemiology Group
European Centre for Disease Prevention and Control @ecdc.europa.eu · 13/11/2025
You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language! Check it out here: vaccination-info.europa.eu/en/rsv #UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
vaccination-info.europa.eu
RSV
Key facts on RSV symptoms, complications, risk factors, how it spreads, prevention, vaccination and treatment.
035
Reposted by ISRV Epidemiology Group
Society for Healthcare Epidemiology of America (SHEA) @sheaepi.bsky.social · 07/11/2025
📢 Call for Abstracts! Submit your abstracts for SHEA Spring 2026 by January 13, 2026, at 11:59 p.m. ET. Don’t miss your chance to share your research with leaders in healthcare epidemiology and infection prevention. bit.ly/4qNoqNU
023
Reposted by ISRV Epidemiology Group
Microbiology Society @microbiologysociety.org · 04/11/2025
One week to go! Abstract submissions for Annual Conference 2026 close at 23:59 GMT on Tuesday 11 November. If you study microbes, there’s a home for your work at #Microbio26 Submit your work to one of >20 available sessions at: microb.io/AC26Abstracts
Night view of Belfast City Hall illuminated with colourful lights, promoting abstract submission closing for Annual Conference 2026 at ICC Belfast from April 13-16.
155
Reposted by ISRV Epidemiology Group
Institut Pasteur Education @pasteuredu.bsky.social · 07/11/2025
🚨 Only 2 weeks left to apply! Pasteur Course: The Last Mile – Towards Elimination of Major Infectious Diseases Join a unique intensive course tackling the current challenges and critical advances in the fight against infectious diseases. 👉 Register now before November 22! bit.ly/4r1RpxE
034
Reposted by ISRV Epidemiology Group
Influenza Update Meetings @influenzaupdate.bsky.social · 05/11/2025
Last chace to register for this year's Influenza Update Meeting - and places are going fast. Don't miss out! Looking forward to seeing you there, flu people
077
Reposted by ISRV Epidemiology Group
David Grimm @david-grimm.bsky.social · 05/11/2025
Getting--or got--a PhD? Got boogie in your soul? Then don't be shy. Enter this year's contest--and dance, dance, dance! @science.org
science.org
Science’s ‘Dance Your Ph.D.’ contest is open again—with an all new, AI twist
For the first time, there’s a special prize for a research-themed dance generated by an artificial intelligence program
12110
Reposted by ISRV Epidemiology Group
British Society for Immunology @britsocimm.bsky.social · 05/11/2025
How can public engagement transform how we teach #Immunology? Join this parallel session organised by the BSI Teaching Affinity Group at BSI Congress to explore how collaboration and lived experience enrich education & research. Register for #BSI25: bit.ly/3IkxWq8
084
Reposted by ISRV Epidemiology Group
ESWI @eswinfluenza.bsky.social · 22/10/2025
#ESWI2025 I #ScienceCommunication #Trust #RiskCommunication #PublicHealth Frédéric Bouder @unistavanger.bsky.social 🇳🇴 ✅ Effective communication of benefits and risks is a key factor in building #Trust 🧭 The three pillars of #Trust: Fairness, Competence, Efficiency
051
Reposted by ISRV Epidemiology Group
ESWI @eswinfluenza.bsky.social · 23/10/2025
📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics A fascinating look at how science reshaped our view of disease and response🧠 #PublicHealth #Pandemic #History
063
Reposted by ISRV Epidemiology Group
ESCAIDE @escaide.eu · 15/10/2025
ESCAIDE 2025 is just around the corner! We are looking forward to seeing you in Warsaw or online on 19-21 November. You can still register to join us virtually: lnkd.in/dHvsXxqr Get a preview of our programme featuring key topics in public health and epidemiology: lnkd.in/d6ZM-ZYT
035
Reposted by ISRV Epidemiology Group
IDWeek @idweek.bsky.social · 20/10/2025
Vaccination against herpes zoster, or shingles, is linked to lower risks of heart disease, dementia and death in people age 50 and older, according to new research presented at #IDWeek2025. bit.ly/471biNp
bit.ly
Shingles Vaccine Lowers Risk of Dementia, Major Cardiovascular Events
0117
Reposted by ISRV Epidemiology Group
Vaccine Safety Initiative @vaccinesafety.bsky.social · 19/10/2025
✈️ Next stop: #ESWI2025 in Valencia! We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation. Looking forward to sharing insights, forging collaborations, and advancing prevention together. #VIVI #InfectionPrevention
145
Reposted by ISRV Epidemiology Group
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 28/09/2025
⏰#ERSCongress ALERT 📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial 🔓 Online now and free to access for all: tinyurl.com/4nhbtj89
001
Reposted by ISRV Epidemiology Group
Ian M. Mackay, PhD (he/him) 🦠🤧🧬📑🦟🧀 @mackayim.bsky.social · 01/10/2025
Long Covid Risk for Children Doubles After a Second Infection, Study Finds. Children you say? #longCOVID www.nytimes.com/2025/09/30/h...
nytimes.com
Long Covid Risk for Children Doubles After a Second Infection, Study Finds
44020
Reposted by ISRV Epidemiology Group
British Society for Immunology @britsocimm.bsky.social · 16/09/2025
Spaces are filling fast! Register for our bioinformatics training starting Monday 20 October 👉 bit.ly/4emxfIt
044
Reposted by ISRV Epidemiology Group
International Society for Infectious Diseases (ISID) @isid.org · 02/09/2025
Thank you for joining @promedmail.org’s 31st anniversary! Your support helps us strengthen systems, better serve our users, and continue sharing trusted outbreak alerts worldwide. Here’s to many more years protecting global health ✨ #ISID ow.ly/En2C50WGWqm
022
Reposted by ISRV Epidemiology Group
FEMS @femsmicro.org · 16/09/2025
Microbial communities of grapevines vary between wine regions, grape variety, climate, geography and vineyard practices. 🍇 This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
buff.ly
#FEMSmicroBlog: Revealing the hidden diversity of wine yeasts
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
051
Reposted by ISRV Epidemiology Group
Vaccine Safety Initiative @vaccinesafety.bsky.social · 12/09/2025
🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5). From surveillance to vaccines, global cooperation is key to staying ahead of future threats. Prevention today means resilience tomorrow. #UnitedInProtection 👉 bit.ly/ViVI-Prep2025
013
Reposted by ISRV Epidemiology Group
CEPI @cepi.net · 12/09/2025
Did you know the next pandemic is likely to emerge from one of 25 or so viral families? Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat. Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
041
Reposted by ISRV Epidemiology Group
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 01/09/2025
📰The Lancet Respiratory Medicine’s September issue is out now Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more Check out the full issue here: bit.ly/3P2PVls
Credit: Adria Volta
059
Reposted by ISRV Epidemiology Group
The Lancet Infectious Diseases @thelancetinfdis.bsky.social · 29/08/2025
New Research: Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial www.thelancet.com/journals/lan...
thelancet.com
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
In patients admitted to hospital with COVID-19 pneumonia, sotrovimab was associated with reduced mortality in the primary analysis population who had a high serum SARS-CoV-2 antigen concentration at b...
102
Reposted by ISRV Epidemiology Group
The Lancet Microbe @lancetmicrobe.bsky.social · 29/07/2025
"On the one hand, we have a hypothesis underpinned by evidence, although imperfect, and on the other hand we have a hypothesis without evidence, although it might exist." Our latest editorial in advance of our August issue www.thelancet.com/journals/lan... #IDSky #ClinMicro #ViroSky #SARS-CoV-2
26536
Reposted by ISRV Epidemiology Group
Open Forum Infectious Diseases @ofidjournal.bsky.social · 27/08/2025
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study ✅ Just Accepted #IDSky
bit.ly
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study
112
Reposted by ISRV Epidemiology Group
International Society for Infectious Diseases (ISID) @isid.org · 21/08/2025
For 31 years, @promedmail.org has led the way in reporting major and minor disease outbreaks, like being the first to alert the world to #COVID19. Our experts work around the clock to detect and share outbreak intelligence worldwide. #ISID Make a gift today: ow.ly/X70M50WGWn4
023
Reposted by ISRV Epidemiology Group
Canada Healthwatch 🍁 @canadahealthwatch.ca · 23/08/2025
Follow the science: ⬇️
canadahealthwatch.ca
Plan for a world of post-COVID immune effects
These changes are small, but across tens of millions of people, they add up.
13713
Reposted by ISRV Epidemiology Group
The Journal of Immunology @jimmunol.bsky.social · 26/08/2025
Dr. John V Williams and his team characterized the role of CD4+ helper T Cells in response to human metapneumovirus (HMPV), identifying a dominant CD4+ T cell epitope and constructing the first MHC-II tetramer for HMPV. Learn more in this #TopRead article: ow.ly/Hern50WJAB3
041
Reposted by ISRV Epidemiology Group
American Society for Virology @amersocvirology.bsky.social · 26/08/2025
Do you love virology but wish you had more colleagues who wanted to discuss the latest papers? FEAR NOT! JVI has you covered with their JVI Seminar Series, where you can hear about a JVI paper directly from the authors. The next seminar is on September 16 at 10am EST: asm.org/webinars/jou...
asm.org
Journal of Virology Seminar Series
Explore cutting-edge virology research in the free monthly Journal of Virology Seminar Series. Authors present their work with live Q&A and discussions led by JVI editors.
0137
Reposted by ISRV Epidemiology Group
Vaccine Safety Initiative @vaccinesafety.bsky.social · 25/08/2025
Stopping Spillover at the Source: #OneHealth Meets #Pandemic #Prevention 🛎️ A new roadmap in Emerging Infectious Diseases outlines how investigating and intercepting virus spillovers early—using integrated, cross‑sector efforts (One Health approach)—can help prevent future pandemics. #ActNow
A visual guide to One Health investigations of spillovers to assist with primary pandemic prevention. One Health investigations trace spillover events backward from detection, systematically uncovering the causal chain that led to spillover. This process involves characterizing the pathogen, contexts, and risks for transmission and determining the reservoir hosts and environmental conditions that enabled the event.
123
Reposted by ISRV Epidemiology Group
International Society of Antimicrobial Chemotherapy @isacworld.bsky.social · 25/08/2025
🧪 Just 1 week left to apply! ISAC Project Grants 2025 offer up to £15,000 for research in #AMR & #infectiousdiseases 🌍 Projects must involve 2 countries (1 LMIC) 📅 Deadline: 1 Sept 📧 secretariat@ISAC.world 🔗 isac.world #GlobalHealth #ISACGrants @heiman-wertheim.bsky.social @souhakanj.bsky.social
023
Reposted by ISRV Epidemiology Group
ESCMID @escmid.bsky.social · 11/08/2025
Today, ESCMID opens the call for late-breaking abstracts for the 6th Conference on #Vaccines in Lisbon. Submit your abstracts and be part of this high-level conference, all about the latest innovations in vaccines. Deadline is 29 Aug⏳ Info: ow.ly/TU6L50WBV0m #IDSky #clinmicro #MedSky
154
Reposted by ISRV Epidemiology Group
CEPI @cepi.net · 11/08/2025
Did you know #AI is already helping the world get ahead of the next pandemic threat? This isn’t about the future, it’s happening now. Discover how CEPI-backed scientists are applying AI to help design better outbreak vaccines faster than ever ⬇️ bit.ly/4kU9s4x
cepi.net
Getting ahead of pandemic threats with better, faster, AI vaccine design | CEPI
032
Reposted by ISRV Epidemiology Group
PIDS @pidsociety.bsky.social · 11/08/2025
Grand Rounds returns Tuesday, August 19 at 1pm ET. Visit our calendar to register for Navigating Training as an IMG Fellow: Practical Tips, Support, and Success.
012
Reposted by ISRV Epidemiology Group
ESCMID @escmid.bsky.social · 12/04/2025
Soon to come in Hall 16, don’t miss the session "Developing guidelines with AI tools: Are they ready for prime time?". Discover how #ArtificialIntelligence could transform the way we create patient-centered guidelines. Be there! #ESCMIDGlobal 2025.
1102
Reposted by ISRV Epidemiology Group
David Hettle @david-hettle.bsky.social · 13/04/2025
#AI is here + will become key in #antimicrobialstewardship #AMS Flagged by Prof Thursky @ncas.bsky.social at #ESCMID2025 #ESCMIDGlobal - this paper is a great blueprint for implementing AI in AMS programmes Link: www.thelancet.com/journals/lan...
095
Reposted by ISRV Epidemiology Group
Chantal Rovers @chantalrovers.bsky.social · 14/04/2025
Listening to @marionkoopmans.bsky.social giving the ESCMID excellence award lecture “Towards pandemic prevention, moonshot or utopia?” at #ESCMIDGlobal @escmid.bsky.social
1215
Reposted by ISRV Epidemiology Group
CMI Communications @cmicomms.bsky.social · 15/04/2025
The session covered not just tips for the submission/revision stages & humanizing peer reviewers but also how to communicate your work! All are on stage taking Qs! @angelahuttner.bsky.social @hoferu.bsky.social @drneilstone.bsky.social @anniejoseph.bsky.social #ESCMIDGlobal #IDSky #clinmicro
0153
Reposted by ISRV Epidemiology Group
Robert Koch-Institut @rki.de · 17/04/2025
1/2 In den letzten 3 Monaten gab es nur 2 Nachweise von Schluckimpfstoff-abgeleiteten #Polioviren im #Abwasser: in Düsseldorf und Hamburg. Erste Funde berichtete das RKI im November – an mehreren Orten und über längere Zeiträume. Mehr im #EpidBull: 🔗 www.rki.de/DE/Aktuelles...
Grafik mit dem Titel „Update zu Poliofunden im Abwasser“. Im Vordergrund ist ein Tropfen Wasser und eine Lupe dargestellt. Die Farben der Illustration sind in Blau- und Lilatönen gehalten.
1215
Reposted by ISRV Epidemiology Group
Journal of Clinical Epidemiology @jclinepi.bsky.social · 17/04/2025
Assessing the Coverage of PubMed, Embase, OpenAlex and Semantic Scholar for Automated Single Database Searches in Living Guideline Evidence Surveillance: A Case Study of the International PCOS Guidelines 2023 - Journal of Clinical Epidemiology www.jclinepi.com/article/S089...
jclinepi.com
Assessing the Coverage of PubMed, Embase, OpenAlex and Semantic Scholar for Automated Single Database Searches in Living Guideline Evidence Surveillance: A Case Study of the International PCOS Guideli...
Living guideline maintenance is underpinned by manual approaches towards evidence retrieval, limiting long term sustainability. Our study aimed to evaluate the feasibility of using only PubMed, Embase...
096
Reposted by ISRV Epidemiology Group
PLOS Global Public Health @plosglobalpublichealth.org · 17/04/2025
Have you checked out our @plos.org Writing Center? There are so many wonderful resources available in this collection of free, practical guides and hands-on resources for authors looking to improve their scientific publishing skillset. plos.org/resources/wr...
plos.org
Writing Center - PLOS
This page is your source for scientific writing & publishing essentials. Learn how to write a successful scientific research article with our free, practical guides and hands-on resources for authors ...
042
Reposted by ISRV Epidemiology Group
ESGREV @esgrev-escmid.bsky.social · 12/04/2025
#ESCMIDGlobal: Outstanding presentation by Eeva Broberg @ecdc.europa.eu on latest developments in #RSV surveillance in the #EU. Newborns are affected by high disease severity whereas the elderly age groups carry the highest risk of mortality due to RSV. @isirvepi.bsky.social @escmid.bsky.social
084
Reposted by ISRV Epidemiology Group
ESGREV @esgrev-escmid.bsky.social · 05/04/2025
Join us at #ESCMIDGlobal next week! #ESGREV open meeting 13 April, 9:30-10:30 #ESGREV / #ISIRV RSV Infections: diagnosis, surveillance and treatment 12 April, 8:30-10:30 #ESGREV / #ICHS Addressing infection challenges in immunocompromised patients 11 April, 16:15-18:15 @escmid.bsky.social
042
Reposted by ISRV Epidemiology Group
The American Association of Immunologists @aai.org · 27/03/2025
Childhood vaccines to prevent illnesses that can cause serious harm or death. Not having to worry about these illnesses anymore is proof that vaccines work. Learn more: ow.ly/SLfi50Vpak2. #ImmunologyExplained #Vaccines #ImmuneSystem
vimeo.com
Immunology Explained: Vaccinating Your Kids
This is "Immunology Explained: Vaccinating Your Kids" by JPA Health on Vimeo, the home for high quality videos and the people who love them.
031